Free shipping on all orders over $ 500


Cat. No. M9221
GSK805 Structure

ROR gamma-t-IN-1

Size Price Availability Quantity
5mg USD 220  USD220 In stock
10mg USD 380  USD380 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
Biological Activity

GSK805 is a potent, orally bioavailable RORγγ Inhibitor, with pIC50 of 8.4 and >8.2 for RORγ FRET assay and Th17 assay. GSK805 suppresses T helper 17 (Th17) responses, including IL-17 and IFN-γ production (~ 500 nM). GSK805 directly and reversibly interacts with the ligand binding domain of RORγt to block its transcriptional effects. GSK805 induces RORγt binding to Gata3 resulting in increased expression of GATA3. GSK805 reduces the severity of autoimmune encephalomyelitis in murine models of multiple sclerosis (30 mg/kg/day, p.o.).

Cell Experiment
Cell lines
Preparation method
Incubation time
Animal Experiment
Animal models EAE mice
Dosages once daily at 3 doses (1, 3, and 10 mg/kg)
Administration orally
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Chemical Information
Molecular Weight 532.36
Formula C23H18Cl2F3NO4S
CAS Number 1426802-50-7
Purity 98.21%
Solubility DMSO 10 mM
Storage -20°C, protect from light

[1] Wang Y, et al. ACS Med Chem Lett. Discovery of Biaryl Amides as Potent, Orally Bioavailable, and CNS Penetrant RORγt Inhibitors.

Related ROR Products

S18-000003 is a potent, effective and orally active inhibitor of retinoic acid receptor-related orphan receptor-gamma-t (RORγt), with an IC50 of 29 nM.


Neoruscogenin is a bioavailable, potent, and high-affinity agonist of the nuclear receptor RORα (NR1F1).


Vimirogant (also known as AGN-242428 and VTP-43742) is a potent, selective and orally active RORγt inhibitor.


SR2211 is a synthetic RORγ-selective modulator, functions as an inverse agonist, with a Ki of 105 nM and an IC50 of ~320 nM.

SR 1001

SR 1001 is a RORα/γ inverse agonist with Ki values of 172 and 111 nM, respectively.

Abmole Inhibitor Catalog

Keywords: GSK805, ROR gamma-t-IN-1 supplier, ROR, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.